<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">0253-0716</issn><issn pub-type="epub">1735-3688</issn><publisher><publisher-name>Iranian Journal of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27840532</article-id><article-id pub-id-type="pmc">5103576</article-id><article-id pub-id-type="publisher-id">IJMS-41-66</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster</subject></subj-group></article-categories><title-group><article-title>The Efficacy of Boswellia Serrata Gum Resin for Control of Lipid Profile and Blood Glucose in Diabetic Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mehrzadi</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tavakolifar</surname><given-names>Bahreh</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huseini</surname><given-names>Hasan Fallah</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mosavat</surname><given-names>Seyed Hamdollah</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Heydari</surname><given-names>Mojtaba</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>2</label>Department of Pharmacology, Alborz University of Medical Sciences, Karaj, Alborz, Iran</aff><aff id="aff3"><label>3</label>Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran</aff><aff id="aff4"><label>4</label>Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</aff><pub-date pub-type="ppub"><month>5</month><year>2016</year></pub-date><volume>41</volume><issue>3 Suppl</issue><fpage>S66</fpage><lpage>S66</lpage><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Medical Sciences</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Regarding preclinical evidence for antidiabetic effects of Boswellia serrata, we evaluated anti-hyperglycemic and lipid-lowering effects of Boswellia serrate gum resin in type 2 diabetic patients in a double-blind randomized placebo-control trial.</p></sec><sec id="st2"><title>Methods:</title><p>Fifty-six diabetic patients were randomly allocated to two groups to receive 250 mg of the Boswellia serrate gum resin or placebo twice daily for 8 weeks, in addition to their routine antidiabetic treatments. Fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), insulin level, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride of serum were measured before and after the intervention.</p></sec><sec id="st3"><title>Results:</title><p>Although there was a considerable reduction after the intervention in FBS (P=0.04), HbA1c (P=0.02) and triglyceride (P=0.01) in the Boswellia serrate gum resin group, no significant difference was observed in all outcome measures between the two groups at the end of the study (FBS P=0.09, HbA1c P=0.20, total cholesterol P=0.31, LDL P=0.49, HDL P=0.10, triglyceride P=0.78 and insulin level P=0.86).</p></sec><sec id="st4"><title>Conclusion:</title><p>The current study showed the 8 weeks complementary use of Boswellia serrate gum resin with a daily dose of 500 mg had no better glucose and lipid lowering effect than placebo in diabetic patients.</p></sec></abstract><kwd-group><kwd>Boswellia</kwd><kwd>Diabetes Mellitus</kwd><kwd>Lipids</kwd><kwd>Complementary Therapies</kwd><kwd>Herbal Medicine</kwd></kwd-group></article-meta></front></article>